Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Amgen Inc. buy UBS Group AG

Start price
€283.85
06.01.26 / 50%
Target price
-
06.01.27
Performance (%)
5.36%
Price
€296.55
08:05
Summary
This prediction is currently active. The BUY prediction by UBS_Group_AG shows slight gains of 5.36%. A total of €2.52 was paid as dividends for this prediction. This prediction currently runs until 06.01.27. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Amgen Inc. -1.409% -1.409%
iShares Core DAX® 3.023% 2.202%
iShares Nasdaq 100 3.561% 1.325%
iShares Nikkei 225® 6.618% 5.707%
iShares S&P 500 2.635% 1.008%

Comments by UBS_Group_AG for this prediction

In the thread Amgen Inc. diskutieren

Amgen (NASDAQ:AMGN) was upgraded by analysts at UBS Group AG from a "neutral" rating to a "buy" rating.
Ratings data for AMGN provided by MarketBeat

Stopped prediction by UBS_Group_AG for Amgen Inc.

buy
Amgen Inc.

Start price
Target price
Perf. (%)
€296.65
13.04.26
€342.24
13.04.27
0.00%
08:05

buy
Amgen Inc.

Start price
Target price
Perf. (%)
€293.05
26.01.26
-
26.01.27
2.05%
08:05